Related Experiment Videos
Predicting Alzheimer's Disease Cognitive Assessment via Robust Low-Rank Structured Sparse Model
Jie Xu1,2, Cheng Deng1, Xinbo Gao1
1Xidian University, Xi'an 710071, China.
IJCAI : Proceedings of the Conference
|April 24, 2018
Summary
This study introduces a new method to identify brain imaging markers for early Alzheimer's disease (AD) detection. The robust low-rank structured sparse regression (RLSR) model improves prediction by considering cognitive score interactions.
Area of Science:
- Neuroscience
- Medical Imaging
- Biostatistics
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Early identification of AD is critical for timely intervention.
- Existing models often overlook the complex interactions between cognitive scores and neuroimaging data.
Purpose of the Study:
- To develop a novel method for identifying informative longitudinal neuroimaging markers for early Alzheimer's disease (AD) detection.
- To predict cognitive measures by effectively utilizing neuroimaging data.
- To address the limitation of existing regression models that do not fully account for interactions between cognitive scores.
Main Methods:
- Proposed a robust low-rank structured sparse regression (RLSR) method.
- Utilized novel mixed structured sparsity-inducing norms and low-rank approximation.
- Developed an efficient algorithm with proven convergence for solving the non-smooth objective function.
Main Results:
- The RLSR method simultaneously selects effective neuroimaging features.
- The model learns the underlying structure between cognitive scores.
- Empirical studies on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrated superior performance compared to existing methods.
Conclusions:
- The proposed RLSR method is effective for identifying neuroimaging markers and predicting cognitive decline in Alzheimer's disease.
- This approach enhances early AD detection by considering cognitive score interactions.
- The findings suggest a promising direction for developing advanced predictive models in neurodegenerative disease research.